Katarzyna Czechowicz
Research Subjects
Katarzyna Czechowicz has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Andżelika Pastuszak
University Clinical Hospital No. 4 in Lublin
6 shared publications - Maciej Błaszczak
University Clinical Hospital No. 4 in Lublin, Poland
5 shared publications - Wiktoria Leja
University Clinical Hospital No. 4 in Lublin
5 shared publications - Jakub Rudnicki
University Clinical Hospital No. 4 in Lublin, Poland
4 shared publications - Katarzyna Latalska
University Clinical Hospital No.4 in Lublin, Poland
4 shared publications - Konrad Borkowski
University Clinical Hospital No. 4 in Lublin
4 shared publications
Latest Publications
- Open Access
- 5 August 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 65, 73883
Impact of Physical Activity and Exercise Modalities on Individual Components of Metabolic Syndrome: A Narrative Review
Background: Metabolic syndrome (MetS) is an increasingly prevalent global health condition that increases the risk of developing type 2 diabetes mellitus and cardiovascular disease. Regular physical activity is recognized as one of the most important modifiable factors in both prevention and management of MetS. Aim: This narrative review evaluated the effect of physical activity on each of the major elements of metabolic syndrome. Material and methods: A narrative review was conducted using a structured search of the PubMed/MEDLINE database. The following keywords were applied: “metabolic syndrome”, “physical activity”, “exercise”, “insulin resistance”, “cardiovascular risk”, “obesity”, “lipid profile”, “blood pressure”, and “inflammation. Only peer-reviewed studies published between 2016 and 2025 were included. Eligible articles comprised randomized controlled trials, systematic reviews, and meta-analyses. Additionally, reference lists of selected studies were screened to identify further relevant publications. Results: The data indicate that regular physical activity results in improvements in multiple aspects of MetS. Most included studies and meta-analyses demonstrated approximately 10-17% declines in visceral fat, improved insulin sensitivity (up to 20-25%), reduced triglycerides (approximately 10-15%) and reduced systolic blood pressure (approximately 7 mmHg). Regular physical activity also resulted in decreased levels of inflammatory biomarkers including C-reactive protein. Conclusions: Physical activity should be incorporated into all prevention and management programs for individuals with metabolic syndrome. When prescribing exercise for individuals with metabolic syndrome, consideration should be given to their initial level of fitness, existing comorbid conditions, potential risks and their likelihood of adhering to the program over time.
- 5 August 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 65, 73883
Open AccessImpact of Physical Activity and Exercise Modalities on Individual Components of Metabolic Syndrome: A Narrative Review
Background: Metabolic syndrome (MetS) is an increasingly prevalent global health condition that increases the risk of developing type 2 diabetes mellitus and cardiovascular disease. Regular physical activity is recognized as one of the most important modifiable factors in both prevention and management of MetS. Aim: This narrative review evaluated the effect of physical activity on each of the major elements of metabolic syndrome. Material and methods: A narrative review was conducted using a structured search of the PubMed/MEDLINE database. The following keywords were applied: “metabolic syndrome”, “physical activity”, “exercise”, “insulin resistance”, “cardiovascular risk”, “obesity”, “lipid profile”, “blood pressure”, and “inflammation. Only peer-reviewed studies published between 2016 and 2025 were included. Eligible articles comprised randomized controlled trials, systematic reviews, and meta-analyses. Additionally, reference lists of selected studies were screened to identify further relevant publications. Results: The data indicate that regular physical activity results in improvements in multiple aspects of MetS. Most included studies and meta-analyses demonstrated approximately 10-17% declines in visceral fat, improved insulin sensitivity (up to 20-25%), reduced triglycerides (approximately 10-15%) and reduced systolic blood pressure (approximately 7 mmHg). Regular physical activity also resulted in decreased levels of inflammatory biomarkers including C-reactive protein. Conclusions: Physical activity should be incorporated into all prevention and management programs for individuals with metabolic syndrome. When prescribing exercise for individuals with metabolic syndrome, consideration should be given to their initial level of fitness, existing comorbid conditions, potential risks and their likelihood of adhering to the program over time.
- Open Access
- 26 May 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (2(50))
REHABILITATION AFTER WHIPLASH INJURY – THE EFFECTIVENESS OF THERAPEUTIC METHODS IN LIGHT OF CLINICAL RESEARCH
Background: Whiplash–associated disorders (WAD) are frequently associated with cervical spine injuries in motor vehicle collisions. Patients commonly experience persistent pain, reduced function, and diminished quality of life. Optimal rehabilitation procedures are still contested. Objectives: The objective of this review was to assess the benefits offered by rehabilitation strategies such as exercise therapy, manual therapy, multimodal programs, psychological interventions, and patient education in WAD. Methods: A review of scientific articles published in PubMed, Embase, Cochrane Library, and Scopus on studies published from 2003 until 2023. Results: Short-term pain and function improved consistently with exercise therapy. Manual therapy offered modest short-term improvement, especially with exercise. Overall, multimodal programs that included exercise, manual therapy, education, and psychological interventions showed better outcomes in pain, function, and quality of life. Cognitive-behavioral therapy and psychological interventions significantly improved recovery among higher-risk patients, and education promoted adherence and engagement. Conclusions: WAD rehabilitation is most likely to be successful once we recognize that active, multimodal therapy, and psychological factors influence WAD response. Early, personalized, and integrated interventions lead to better patient outcomes and may prevent chronic pain and disability.
- 26 May 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (2(50))
Open AccessREHABILITATION AFTER WHIPLASH INJURY – THE EFFECTIVENESS OF THERAPEUTIC METHODS IN LIGHT OF CLINICAL RESEARCH
Background: Whiplash–associated disorders (WAD) are frequently associated with cervical spine injuries in motor vehicle collisions. Patients commonly experience persistent pain, reduced function, and diminished quality of life. Optimal rehabilitation procedures are still contested. Objectives: The objective of this review was to assess the benefits offered by rehabilitation strategies such as exercise therapy, manual therapy, multimodal programs, psychological interventions, and patient education in WAD. Methods: A review of scientific articles published in PubMed, Embase, Cochrane Library, and Scopus on studies published from 2003 until 2023. Results: Short-term pain and function improved consistently with exercise therapy. Manual therapy offered modest short-term improvement, especially with exercise. Overall, multimodal programs that included exercise, manual therapy, education, and psychological interventions showed better outcomes in pain, function, and quality of life. Cognitive-behavioral therapy and psychological interventions significantly improved recovery among higher-risk patients, and education promoted adherence and engagement. Conclusions: WAD rehabilitation is most likely to be successful once we recognize that active, multimodal therapy, and psychological factors influence WAD response. Early, personalized, and integrated interventions lead to better patient outcomes and may prevent chronic pain and disability.
- Open Access
- 27 April 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (2(50))
CLINICAL IMPACT OF DEPRESSION ON TREATMENT OUTCOMES IN RHEUMATOID ARTHRITIS: A LITERATURE REVIEW
Depression is a common comorbidity in rheumatoid arthritis, however we still don't know enough about how it affects treatment outcomes. This systematic review aims to assess the clinical influence of depression on disease activity, remission rates, pharmacological treatment response, patient-reported outcomes, and treatment adherence behaviour in individuals with rheumatoid arthritis. A thorough literature review was performed using PubMed, Scopus and Web of Science. We focused on studies published from 2020 to 2026 that evaluated depressive symptoms through validated instruments and reported at least one treatment-related outcome. The results consistently indicated that comorbid depression correlated with greatly elevated composite disease activity scores. It was mostly influenced by subjective rather than objective components. Patients exhibiting depressive symptoms were less likely to attain remission and demonstrated diminished responses to both conventional synthetic and biologic disease-modifying antirheumatic drugs. Depression was also found to be a strong independent predictor of worse health-related quality of life, more pain, more functional disability and less adherence to treatment. These findings underscore the necessity for regular depression screening in rheumatology practice and advocate for the incorporation of mental health interventions into the management of rheumatoid arthritis to enhance treatment outcomes.
- 27 April 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (2(50))
Open AccessCLINICAL IMPACT OF DEPRESSION ON TREATMENT OUTCOMES IN RHEUMATOID ARTHRITIS: A LITERATURE REVIEW
Depression is a common comorbidity in rheumatoid arthritis, however we still don't know enough about how it affects treatment outcomes. This systematic review aims to assess the clinical influence of depression on disease activity, remission rates, pharmacological treatment response, patient-reported outcomes, and treatment adherence behaviour in individuals with rheumatoid arthritis. A thorough literature review was performed using PubMed, Scopus and Web of Science. We focused on studies published from 2020 to 2026 that evaluated depressive symptoms through validated instruments and reported at least one treatment-related outcome. The results consistently indicated that comorbid depression correlated with greatly elevated composite disease activity scores. It was mostly influenced by subjective rather than objective components. Patients exhibiting depressive symptoms were less likely to attain remission and demonstrated diminished responses to both conventional synthetic and biologic disease-modifying antirheumatic drugs. Depression was also found to be a strong independent predictor of worse health-related quality of life, more pain, more functional disability and less adherence to treatment. These findings underscore the necessity for regular depression screening in rheumatology practice and advocate for the incorporation of mental health interventions into the management of rheumatoid arthritis to enhance treatment outcomes.
- Open Access
- 17 April 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 54
Impact of Pilot Fatigue and Sleep Deprivation on Cognitive Performance and Flight Safety – A Narrative Review
Pilot fatigue and sleep deprivation are two very serious and persistent risks to global aviation safety. In particular night flying and cross-continental travels result in a continuous fatigue build-up and may lead to diminished pilots’ performance. This review combines findings from recent research concerning the impact of sleep loss and fatigue on the cognition of pilots. In particular factors like working memory, focusing attention, reaction times, decision making and situational awareness are discussed. The presented review demonstrated that moderate levels of sleep deprivation lead to measurable decreases in human alertness, psychomotor speed and executive functioning. Moreover, it was proved fatigue played a pivot role in a large number of aviation incidents and accidents. Presented reports indicate that aviation regulatory agencies, airline managers and researchers should give high priority to reducing pilot fatigue in order to protect both the health of pilots and the safety of passengers.
- 17 April 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 54
Open AccessImpact of Pilot Fatigue and Sleep Deprivation on Cognitive Performance and Flight Safety – A Narrative Review
Pilot fatigue and sleep deprivation are two very serious and persistent risks to global aviation safety. In particular night flying and cross-continental travels result in a continuous fatigue build-up and may lead to diminished pilots’ performance. This review combines findings from recent research concerning the impact of sleep loss and fatigue on the cognition of pilots. In particular factors like working memory, focusing attention, reaction times, decision making and situational awareness are discussed. The presented review demonstrated that moderate levels of sleep deprivation lead to measurable decreases in human alertness, psychomotor speed and executive functioning. Moreover, it was proved fatigue played a pivot role in a large number of aviation incidents and accidents. Presented reports indicate that aviation regulatory agencies, airline managers and researchers should give high priority to reducing pilot fatigue in order to protect both the health of pilots and the safety of passengers.
- Open Access
- 14 April 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (2(50))
ESTABLISHED AND EMERGING BIOMARKERS OF INFLAMMATION IN RHEUMATOID ARTHRITIS: A LITERATURE REVIEW
Background and Objective: Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease characterized by persistent inflammation, progressive joint damage, and systemic consequences contributing to increased morbidity and mortality. Although conventional biomarkers are fundamental for diagnosis and disease activity assessment, their prognostic accuracy remains limited. This review aimed to summarize current evidence on emerging inflammatory biomarkers in RA, with emphasis on their prognostic value and translational relevance for personalized disease management. Methods: A structured literature search was conducted in major scientific databases, covering English-language publications from 2014 to March 2025. Studies were selected according to predefined inclusion criteria to identify clinically relevant data on novel inflammatory biomarkers in RA. Results: Emerging biomarkers, including novel autoantibodies, 14-3-3η protein, calprotectin, selected cytokines, adipokines, circulating microRNAs, and hematological inflammatory indices, provide complementary insights into immune dysregulation and systemic inflammation. Several markers are associated with radiographic progression, extra-articular involvement, and treatment response. Multibiomarker disease activity scores represent an integrative approach linking molecular pathways with clinical assessment and risk stratification. Conclusions: Integration of conventional and emerging biomarkers may enhance prognostic precision and support precision medicine strategies in RA. However, robust prospective validation and cost-effectiveness analyses are required before routine clinical implementation.
- 14 April 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (2(50))
Open AccessESTABLISHED AND EMERGING BIOMARKERS OF INFLAMMATION IN RHEUMATOID ARTHRITIS: A LITERATURE REVIEW
Background and Objective: Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease characterized by persistent inflammation, progressive joint damage, and systemic consequences contributing to increased morbidity and mortality. Although conventional biomarkers are fundamental for diagnosis and disease activity assessment, their prognostic accuracy remains limited. This review aimed to summarize current evidence on emerging inflammatory biomarkers in RA, with emphasis on their prognostic value and translational relevance for personalized disease management. Methods: A structured literature search was conducted in major scientific databases, covering English-language publications from 2014 to March 2025. Studies were selected according to predefined inclusion criteria to identify clinically relevant data on novel inflammatory biomarkers in RA. Results: Emerging biomarkers, including novel autoantibodies, 14-3-3η protein, calprotectin, selected cytokines, adipokines, circulating microRNAs, and hematological inflammatory indices, provide complementary insights into immune dysregulation and systemic inflammation. Several markers are associated with radiographic progression, extra-articular involvement, and treatment response. Multibiomarker disease activity scores represent an integrative approach linking molecular pathways with clinical assessment and risk stratification. Conclusions: Integration of conventional and emerging biomarkers may enhance prognostic precision and support precision medicine strategies in RA. However, robust prospective validation and cost-effectiveness analyses are required before routine clinical implementation.
- Open Access
- 10 April 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 54
Preoperative Optimization in Total Knee Arthroplasty: Beyond Weight Loss
Total knee arthroplasty is one of the most commonly performed orthopaedic surgeries worldwide. However, a significant number of patients experience post-operative complications and do not achieve satisfactory functional results after their surgical procedure. While obesity has been the main focus in pre-operative risk discussions for many years, more recent evidence indicates that there are several other modifiable factors which have equal to or greater prognostic value than obesity. This narrative review will synthesis current evidence on these same five key domains of optimization prior to surgery: glycemic control; nutritional status; physical conditioning; psychological readiness; and broader comorbidity management. Diabetes mellitus and perioperative hyperglycemia consistently have higher rates of wound dehiscence, readmission and periprosthetic joint infection. Malnourishment before surgery (up to 40% of patients undergoing arthroplasty) individually increases the risk of early implant failure and wound complications. Structured prehabilitation programs enhance functional capacity in the weeks leading up to surgery and accelerate recovery following surgery. Benefits from prehabilitation are greatest among those with the lowest levels of functional ability at baseline. Depression, anxiety, kinesiophobia and unreasonable expectations by patients are among the strongest independent predictors of poor reported outcomes and patient dissatisfaction following surgery. Finally, both preoperative anemia and smoking each contribute to adverse outcomes as well as overall comorbidity burden. The evidence supports moving away from weight-centred risk stratification towards a multidisciplinary approach to optimize all domains prior to surgery. Systematic screening for these domains and targeted intervention may result in reduced complication rates and improved reported outcomes.
- 10 April 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 54
Open AccessPreoperative Optimization in Total Knee Arthroplasty: Beyond Weight Loss
Total knee arthroplasty is one of the most commonly performed orthopaedic surgeries worldwide. However, a significant number of patients experience post-operative complications and do not achieve satisfactory functional results after their surgical procedure. While obesity has been the main focus in pre-operative risk discussions for many years, more recent evidence indicates that there are several other modifiable factors which have equal to or greater prognostic value than obesity. This narrative review will synthesis current evidence on these same five key domains of optimization prior to surgery: glycemic control; nutritional status; physical conditioning; psychological readiness; and broader comorbidity management. Diabetes mellitus and perioperative hyperglycemia consistently have higher rates of wound dehiscence, readmission and periprosthetic joint infection. Malnourishment before surgery (up to 40% of patients undergoing arthroplasty) individually increases the risk of early implant failure and wound complications. Structured prehabilitation programs enhance functional capacity in the weeks leading up to surgery and accelerate recovery following surgery. Benefits from prehabilitation are greatest among those with the lowest levels of functional ability at baseline. Depression, anxiety, kinesiophobia and unreasonable expectations by patients are among the strongest independent predictors of poor reported outcomes and patient dissatisfaction following surgery. Finally, both preoperative anemia and smoking each contribute to adverse outcomes as well as overall comorbidity burden. The evidence supports moving away from weight-centred risk stratification towards a multidisciplinary approach to optimize all domains prior to surgery. Systematic screening for these domains and targeted intervention may result in reduced complication rates and improved reported outcomes.
- Open Access
- 30 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (1(49))
THE ROLE OF GUT MICROBIOTA IN THE PATHOGENESIS OF POLYCYSTIC OVARY SYNDROME
Introduction and aim of the study: Polycystic ovary syndrome (PCOS) is a multifactorial endocrine–metabolic condition affecting a significant proportion of women of reproductive age. Recent scientific evidence suggests that disturbances in gut microbiota composition may play an important role in the metabolic, hormonal and inflammatory abnormalities characteristic of PCOS. The aim of this review was to summarize current knowledge on the relationship between gut microbiota and PCOS, with particular emphasis on pathophysiological mechanisms and potential therapeutic implications. Materials and Methods: This review was conducted through a systematic search of the PubMed database, using keywords related to PCOS, gut microbiota, dysbiosis, insulin resistance and hormonal imbalance. Relevant original research articles were analyzed to identify common mechanisms and clinically meaningful associations. Results: Findings indicate that gut dysbiosis in PCOS is closely linked to increased intestinal permeability, chronic low-grade inflammation, altered short-chain fatty acid (SCFA) production and disturbances in bile acid and tryptophan metabolism. These changes interact with key endocrine pathways regulating insulin sensitivity, androgen excess and estrogen conversion. Recent studies also highlight the therapeutic potential of dietary interventions, probiotics, prebiotics, synbiotics and bioactive nutrients, which can help restore microbial balance and improve metabolic and hormonal outcomes. Conclusions: Understanding the role of the gut microbiota in PCOS pathogenesis opens new perspectives for adjunctive therapeutic strategies. Microbiota-targeted interventions may provide meaningful support alongside conventional treatment, helping to address underlying mechanisms rather than only managing symptoms.
- 30 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (1(49))
Open AccessTHE ROLE OF GUT MICROBIOTA IN THE PATHOGENESIS OF POLYCYSTIC OVARY SYNDROME
Introduction and aim of the study: Polycystic ovary syndrome (PCOS) is a multifactorial endocrine–metabolic condition affecting a significant proportion of women of reproductive age. Recent scientific evidence suggests that disturbances in gut microbiota composition may play an important role in the metabolic, hormonal and inflammatory abnormalities characteristic of PCOS. The aim of this review was to summarize current knowledge on the relationship between gut microbiota and PCOS, with particular emphasis on pathophysiological mechanisms and potential therapeutic implications. Materials and Methods: This review was conducted through a systematic search of the PubMed database, using keywords related to PCOS, gut microbiota, dysbiosis, insulin resistance and hormonal imbalance. Relevant original research articles were analyzed to identify common mechanisms and clinically meaningful associations. Results: Findings indicate that gut dysbiosis in PCOS is closely linked to increased intestinal permeability, chronic low-grade inflammation, altered short-chain fatty acid (SCFA) production and disturbances in bile acid and tryptophan metabolism. These changes interact with key endocrine pathways regulating insulin sensitivity, androgen excess and estrogen conversion. Recent studies also highlight the therapeutic potential of dietary interventions, probiotics, prebiotics, synbiotics and bioactive nutrients, which can help restore microbial balance and improve metabolic and hormonal outcomes. Conclusions: Understanding the role of the gut microbiota in PCOS pathogenesis opens new perspectives for adjunctive therapeutic strategies. Microbiota-targeted interventions may provide meaningful support alongside conventional treatment, helping to address underlying mechanisms rather than only managing symptoms.
- Open Access
- 23 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (1(49))
CLINICAL PRESENTATION OF LEFT VENTRICULAR NONCOMPACTION DIAGNOSED IN ADULTS
Left ventricular noncompaction (LVNC) is a rare, morphologically and genetically heterogeneous form of cardiomyopathy, the pathogenesis, classification, and clinical significance of which remain subjects of ongoing debate. The aim of this review is to present the current state of knowledge regarding the classification, pathophysiology, diagnostics, genetic determinants, clinical presentation, and therapeutic management of LVNC. The European Society of Cardiology (ESC) classifies LVNC as an unclassified cardiomyopathy, whereas the American Heart Association (AHA) considers it a genetically determined cardiac disorder. The characteristic morphology arises from abnormal compaction of the left ventricular trabeculae during embryogenesis, although an acquired or adaptive origin of these changes is also possible. Diagnostic evaluation relies primarily on echocardiography and cardiac magnetic resonance imaging; however, the lack of uniform morphological criteria contributes to both overdiagnosis and underdiagnosis. From a genetic perspective, sarcomeric gene mutations predominate and are associated with more severe clinical outcomes. Clinical manifestations include heart failure, arrhythmias, and thromboembolic complications, with reduced left ventricular ejection fraction being the principal prognostic factor. Therapeutic management follows general heart failure treatment strategies, thromboembolism prevention, and implantation of cardiac devices; in advanced cases, heart transplantation or mechanical circulatory support may be considered. An integrated diagnostic approach and the MOGE(S) classification system may serve as a foundation for future standardization.
- 23 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (1(49))
Open AccessCLINICAL PRESENTATION OF LEFT VENTRICULAR NONCOMPACTION DIAGNOSED IN ADULTS
Left ventricular noncompaction (LVNC) is a rare, morphologically and genetically heterogeneous form of cardiomyopathy, the pathogenesis, classification, and clinical significance of which remain subjects of ongoing debate. The aim of this review is to present the current state of knowledge regarding the classification, pathophysiology, diagnostics, genetic determinants, clinical presentation, and therapeutic management of LVNC. The European Society of Cardiology (ESC) classifies LVNC as an unclassified cardiomyopathy, whereas the American Heart Association (AHA) considers it a genetically determined cardiac disorder. The characteristic morphology arises from abnormal compaction of the left ventricular trabeculae during embryogenesis, although an acquired or adaptive origin of these changes is also possible. Diagnostic evaluation relies primarily on echocardiography and cardiac magnetic resonance imaging; however, the lack of uniform morphological criteria contributes to both overdiagnosis and underdiagnosis. From a genetic perspective, sarcomeric gene mutations predominate and are associated with more severe clinical outcomes. Clinical manifestations include heart failure, arrhythmias, and thromboembolic complications, with reduced left ventricular ejection fraction being the principal prognostic factor. Therapeutic management follows general heart failure treatment strategies, thromboembolism prevention, and implantation of cardiac devices; in advanced cases, heart transplantation or mechanical circulatory support may be considered. An integrated diagnostic approach and the MOGE(S) classification system may serve as a foundation for future standardization.